Abnormal Glycosylation of Cancer Stem Cells and Targeting Strategies

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Cancer stem cells (CSCs) are a primary cause of tumor relapse and therapy resistance.
• Intracellular signaling pathways and extracellular features regulate CSC properties like heterogeneity and differentiation.
• Aberrant glycosylation is linked to CSC survival, self-renewal, and extravasation.

Purpose of the Study:

• To review the critical role of glycosylation in maintaining CSC stemness.
• To explore strategies for targeting abnormal glycosylation to eradicate CSCs.

Main Methods:

• Literature review focusing on glycosylation's role in CSCs.
• Analysis of signaling pathways and markers affected by glycosylation.
• Evaluation of therapeutic strategies targeting glycosylation.

Main Results:

• Glycosylation significantly promotes CSC stemness and survival.
• Aberrant glycosylation patterns are associated with key CSC functions.
• Targeting glycosylation presents a viable approach to eliminate resistant CSCs.

Conclusions:

• Glycosylation is a key regulator of cancer stem cell properties.
• Targeting aberrant glycosylation offers a novel therapeutic avenue for overcoming treatment resistance and preventing cancer relapse.